Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cheryl Attard"'
Autor:
Shaun G. Goodman, Daniel T. Grima, Chi-Ming Chow, Lawrence A. Leiter, Anatoly Langer, Cheryl Attard
Publikováno v:
Canadian Journal of Cardiology. 24:363-368
Background Strong evidence exists to support the use of statins, acetylsalicylic acid (ASA) and angiotensin-converting enzyme inhibitors (ACEI) in patients at high risk of cardiovascular (CV) events; however, current practice pattern data indicate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76aa1d1eeae14caa9f938fb80c6d85eb
https://doi.org/10.1016/s0828-282x(08)70597-x
https://doi.org/10.1016/s0828-282x(08)70597-x
Publikováno v:
Nephron. Clinical practice. 106(4)
Background: Treatment of anemia in hemodialysis patients usually requires the use of expensive erythropoietic proteins. Cost analyses usually focus on drug acquisition costs. Other costs associated with anemia therapy include resources for anemia mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6145b02767ad61ec95b1aa4d2352ee4
https://pubmed.ncbi.nlm.nih.gov/17596729
https://pubmed.ncbi.nlm.nih.gov/17596729
Publikováno v:
Ostomy/wound management. 49(11)
Foot ulcers secondary to peripheral neuropathy and vascular disease are a commonly occurring complication for people with diabetes. Becaplermin, a genetically-engineered growth factor in a hydrogel vehicle, has been shown to be more effective than ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6bc61fec312ad5f41b7e7020c757bc7c
https://pubmed.ncbi.nlm.nih.gov/14652415
https://pubmed.ncbi.nlm.nih.gov/14652415
Autor:
Raafat Bishai, Gideon Koren, Kiran Chandra, Laura A. Magee, Caroline Maltepe, Yvette Navioz, Cheryl Attard, Michele Kohli, Gordana Atanackovic
Publikováno v:
European journal of obstetrics, gynecology, and reproductive biology. 94(1)
The symptomatology of nausea and vomiting of pregnancy (NVP) ranges from mild to very severe. The most advanced method to measure the burden of NVP, the Rhode’s scores, incorporates physical signs (length and number of episodes of nausea, number an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f9dfc5045d2721dc78928c22c3d6852
https://pubmed.ncbi.nlm.nih.gov/11134823
https://pubmed.ncbi.nlm.nih.gov/11134823
Autor:
Eugene Daphnis, Atsushi Ueda, Giuseppe Signoriello, Tiziana Ciarambino, Liqun He, Nicola Ferrara, Giuseppe Paolisso, Paolo Tirelli, Inga Soveri, May Chan, Cheryl Attard, John Kyriazis, Joel Kallich, Kai-Ming Chow, Michihiro Gotoh, Bengt Fellström, Michael G. Alexandrakis, Kam-Tao Philip Li, David N. Churchill, David Macarios, Takashi Ishizu, Fernand Mac-Moune Lai, Akio Koyama, Kostas Stylianou, Spyros Stratigis, Yoshinori Taru, Steven Fishbane, Gang Wang, Clarence P. Alfrey, Eleftheria Vardaki, Kersti Zilmer, Kunihiro Yamagata, Björn Wikström, Michele Varricchio, Irene Xylouri, Peicheng Shen, Cheuk-Chun Szeto, Lars Lind, Ron Goeree, Mauro Giordano, Mihkel Zilmer, Ka-Bik Lai, Yi Li, Mami Obara, Sohji Nagase, Yukari Shimozawa, Antonio Gambardella, Yunman Wang, Aki Hirayama
Publikováno v:
Nephron Clinical Practice. 106:c200-c200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbcf717dd9b2460e2ab129de17c34299
https://doi.org/10.1159/000106765
https://doi.org/10.1159/000106765
Publikováno v:
Blood. 108:5517-5517
Multiple myeloma (MM) is an incurable disease with poor survival outcomes. Recent trials have suggested improved overall survival with newer agents like bortezomib (VELCADE). In the process of developing a life-time cost-effectiveness analysis of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dae9741482af154baa6704571c2d1578
https://doi.org/10.1182/blood.v108.11.5517.5517
https://doi.org/10.1182/blood.v108.11.5517.5517
Publikováno v:
Current Medical Research & Opinion; Feb2011, Vol. 27 Issue 2, p383-391, 9p